{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:25:44Z","timestamp":1792743944208,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.prp.2025.155913","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:37:48Z","timestamp":1742053068000},"page":"155913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Theranostic implications of Nectin-4 oncoprotein in gynecologic cancers: A review"],"prefix":"10.1016","volume":"269","author":[{"given":"Olivia","family":"Hooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin T.","family":"Childers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily T.","family":"Childers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5180-0409","authenticated-orcid":false,"given":"Sarfraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155913_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2025.155913_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2025.155913_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"A. Jemal, Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2025.155913_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/agm2.12297","article-title":"Trends in gynecological cancer incidence, mortality, and survival among elderly women: A SEER study","volume":"7","author":"Priyadarshini","year":"2024","journal-title":"Aging Med (Milton)"},{"key":"10.1016\/j.prp.2025.155913_bib5","first-page":"1","article-title":"Novel Therapies in Gynecologic Cancer","volume":"42","author":"Bejar","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.prp.2025.155913_bib6","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2022.33.e43","article-title":"Major clinical research advances in gynecologic cancer in 2021","volume":"33","author":"Park","year":"2022","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.prp.2025.155913_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41392-024-01826-z","article-title":"Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities","volume":"9","author":"Yin","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.155913_bib8","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00358","article-title":"A role for PVRL4-driven cell-cell interactions in tumorigenesis","volume":"2","author":"Pavlova","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.prp.2025.155913_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1159\/000108103","article-title":"Nectin and nectin-like molecules: biology and pathology","volume":"27","author":"Miyoshi","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.prp.2025.155913_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00018-014-1763-4","article-title":"Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity","volume":"72","author":"Samanta","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prp.2025.155913_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","article-title":"Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker","volume":"134","author":"Derycke","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2025.155913_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.cellbio.24.110707.175339","article-title":"The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin","volume":"24","author":"Takai","year":"2008","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2025.155913_bib13","doi-asserted-by":"crossref","first-page":"43205","DOI":"10.1074\/jbc.M103810200","article-title":"Nectin4\/PRR4, a New Afadin-associated Member of the Nectin Family That Trans-interacts with Nectin1\/PRR1 through V Domain Interaction","volume":"276","author":"Reymond","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2025.155913_bib14","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5273","article-title":"Role of Nectin4 protein in cancer (Review)","volume":"59","author":"Liu","year":"2021","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.prp.2025.155913_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174516","article-title":"Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy","volume":"911","author":"Chatterjee","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2025.155913_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2407-7-73","article-title":"Nectin-4 is a new histological and serological tumor associated marker for breast cancer","volume":"7","author":"Fabre-Lafay","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2025.155913_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12935-022-02669-w","article-title":"Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K\/AKT\/NF-B signaling by down-regulation of miR-520c-3p","volume":"22","author":"Liu","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2025.155913_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-019-0824-z","article-title":"Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients","volume":"19","author":"Deng","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2025.155913_bib19","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","article-title":"Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer","volume":"69","author":"Takano","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2025.155913_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13046-015-0144-7","article-title":"Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer","volume":"34","author":"Nishiwada","year":"2015","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.155913_bib21","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1158\/0008-5472.CAN-15-1313","article-title":"Enfortumab vedotin antibody-drug conjugate targeting Nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models","volume":"76","author":"Challita-Eid","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2025.155913_bib22","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3390\/ijms21134637","article-title":"Skubitz, Inhibition of ovarian cancer cell spheroid formation by synthetic peptides derived from Nectin-4","volume":"21","author":"Boylan","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155913_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173308","article-title":"Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells","volume":"883","author":"Chatterjee","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.prp.2025.155913_bib24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2147\/OTT.S370900","article-title":"Targeted treatment of locally advanced and metastatic urothelial cancer: Enfortumab vedotin in context","volume":"15","author":"Hoffman-Censits","year":"2022","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2025.155913_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12951-024-02521-5","article-title":"A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer","volume":"22","author":"Wu","year":"2024","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.prp.2025.155913_bib26","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/CM9.0000000000002328","article-title":"Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer","volume":"136","author":"Liu","year":"2023","journal-title":"Chin. Med J."},{"key":"10.1016\/j.prp.2025.155913_bib27","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/cancers11050698","article-title":"NECTIN4 (PVRL4) as putative therapeutic target for a specific subtype of high grade serous ovarian cancer: An integrative multi-omics approach","volume":"11","author":"Bekos","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2025.155913_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/cancers10090295","article-title":"Epigenetic crosstalk between the tumor microenvironment and ovarian cancer cells: A therapeutic road less traveled","volume":"10","author":"Klymenko","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.155913_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13048-020-00725-5","article-title":"Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer","volume":"13","author":"Gong","year":"2020","journal-title":"J. Ovarian Res"},{"key":"10.1016\/j.prp.2025.155913_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10585-013-9615-4","article-title":"Metastasis of ovarian cancer is mediated by kallikrein related peptidases","volume":"31","author":"Dong","year":"2014","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.prp.2025.155913_bib31","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.18632\/oncotarget.14206","article-title":"The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate","volume":"8","author":"Boylan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155913_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/1354750X.2014.940503","article-title":"The diagnostic efficacy of nectin 4 expression in ovarian cancer patients","volume":"19","author":"Nabih","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.prp.2025.155913_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1541-7786.MCR-16-0097","article-title":"DNA methylome analyses implicate fallopian tube epithelia as the origin for high-grade serous ovarian cancer","volume":"14","author":"Klinkebiel","year":"2016","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.prp.2025.155913_bib34","article-title":"High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: A case report","volume":"13","author":"Giancontieri","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.155913_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235867","article-title":"Nectin-4 as blood-based biomarker enables detection of early ovarian cancer stages","volume":"14","author":"Rogmans","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2025.155913_bib36","volume":"2023","author":"Center","year":"2023","journal-title":"Glob. State Cerv. Cancer Aware. Rep."},{"key":"10.1016\/j.prp.2025.155913_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13402-018-0417-1","article-title":"Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation","volume":"42","author":"Nayak","year":"2019","journal-title":"Cell Oncol."},{"key":"10.1016\/j.prp.2025.155913_bib38","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acs.molpharmaceut.5b00461","article-title":"Enhancement of cytotoxicity and inhibition of angiogenesis in oral cancer stem cells by a hybrid nanoparticle of bioactive Quinacrine and Silver: Implication of base excision repair cascade","volume":"12","author":"Satapathy","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.prp.2025.155913_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-015-2794-8","article-title":"NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K\u2013AKT cascade","volume":"76","author":"Das","year":"2015","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.prp.2025.155913_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep20600","article-title":"Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1","volume":"6","author":"Nayak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.155913_bib41","author":"Synapse","year":"2024","journal-title":"Mabwell'S. Nov. ADC Targets Nectin-4, shows promise Cerv. Cancer Treat."},{"key":"10.1016\/j.prp.2025.155913_bib42","series-title":"The first published clinical data of Nectin-4-targeting ADC developed by Mabwell in cervical cancer demonstrates its outstanding therapeutic potential","author":"PR Newswire","year":"2024"},{"key":"10.1016\/j.prp.2025.155913_bib43","author":"ClinicalTrials.gov","year":"2024","journal-title":"A Study ADRX-0706 Sel. Adv. Solid Tumors"},{"key":"10.1016\/j.prp.2025.155913_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2025.155913_bib45","unstructured":"C.M. Mahdy H, E.S. Vadakekut, D. Crotzer, Endometrial cancer, StatPearls (2024). \u3008https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30252237\u3009."},{"key":"10.1016\/j.prp.2025.155913_bib46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0960-0760(91)90310-2","article-title":"Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin","volume":"40","author":"Pugeat","year":"1991","journal-title":"J. Steroid Biochem Mol. Biol."},{"key":"10.1016\/j.prp.2025.155913_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.155913_bib48","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/cas.14344","article-title":"Estrogen-related receptor- promotes gallbladder cancer development by enhancing the transcription of Nectin-4","volume":"111","author":"Wang","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2025.155913_bib49","doi-asserted-by":"crossref","first-page":"16963","DOI":"10.18632\/aging.103611","article-title":"PGC-1 and ERR in patients with endometrial cancer: A translational study for predicting myometrial invasion","volume":"12","author":"Chen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.prp.2025.155913_bib50","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3390\/cancers15102865","article-title":"Nectin-4 as a predictive marker for poor prognosis of endometrial cancer with mismatch tepair impairment","volume":"15","author":"Chang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2025.155913_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular genetics of endometrial carcinoma","volume":"14","author":"Bell","year":"2019","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.prp.2025.155913_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12885-022-09259-z","article-title":"Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: An ImGO pilot study","volume":"22","author":"Calandrella","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2025.155913_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1223","article-title":"FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signaling pathways","volume":"13","author":"Dixit","year":"2023","journal-title":"Clin. Transl. Med"},{"key":"10.1016\/j.prp.2025.155913_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3889\/oamjms.2017.044","article-title":"Primary fallopian tube carcinoma: A case report and literature review","volume":"5","author":"Rexhepi","year":"2017","journal-title":"Maced. J. Med Sci."},{"key":"10.1016\/j.prp.2025.155913_bib55","unstructured":"National Cancer Institute, Cancer Stat Facts: Vulvar cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/vulva.html, 2024 (accessed August 13, 2024)."},{"key":"10.1016\/j.prp.2025.155913_bib56","unstructured":"D.C. Kaltenecker B, Tikaria R., Vaginal cancer, StatPearls (2024). \u3008https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32644552\u3009."},{"key":"10.1016\/j.prp.2025.155913_bib57","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(84)90444-7","article-title":"Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix","volume":"148","author":"Niloff","year":"1984","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2025.155913_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","article-title":"Endometriosis","volume":"4","author":"Zondervan","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2025.155913_bib59","doi-asserted-by":"crossref","first-page":"463","DOI":"10.12891\/ceog2150.2016","article-title":"The role of the adhesion molecule Nectin-4 in the pathogenesis of endometriosis","volume":"43","author":"Bedir","year":"2016","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.prp.2025.155913_bib60","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1093\/humrep\/des304","article-title":"Eutopic endometrium and peritoneal, ovarian and colorectal endometriotic tissues express a different profile of nectin-1, -3, -4 and nectin-like molecule 2","volume":"27","author":"Ballester","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.prp.2025.155913_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12881-018-0681-y","article-title":"Potential role for nectin-4 in the pathogenesis of pre-eclampsia: A molecular genetic study","volume":"19","author":"Ito","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.prp.2025.155913_bib62","first-page":"200","article-title":"Increased levels of nectin-4 as a serological marker for pre-eclampsia","volume":"9","author":"Yoshizawa","year":"2023","journal-title":"Fujita Med J."},{"key":"10.1016\/j.prp.2025.155913_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-0528.2004.00438.x","article-title":"Extramammary Paget's disease","volume":"112","author":"Shepherd","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.prp.2025.155913_bib64","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3390\/ijms21165891","article-title":"NECTIN4 expression in extramammary Paget's disease: Implication of a new therapeutic target","volume":"21","author":"Murata","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.155913_bib65","unstructured":"BioRender. bioRender \u3008https:\/\/www.biorender.com\/\u3009 (accessed December 8, 2024)."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:47:28Z","timestamp":1749206848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825001050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":65,"alternative-id":["S0344033825001050"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155913","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Theranostic implications of Nectin-4 oncoprotein in gynecologic cancers: A review","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155913"}}